Cytokines in genetic susceptibility to
multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
Date: January 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group. Reboul J, Mertens C, Levillayer F, Eichenbaum-Voline S, Vilkoren T, Cournu I, Babron MC, Lyon-Caen O, Clerget-Darpoux F, Edan G, Clanet M, Brahic M, Bureau JF, Fontaine B, Liblau R Laboratoire d'Immunologie Cellulaire, Hopital Pitie-Salpetriere, Paris, France.
The immune system is involved in the pathophysiology of multiple sclerosis (MS) but the initiating antigen(s) is not yet identified. Since cytokines control both the intensity and the quality of the immune response they may be relevant candidates for the genetic susceptibility to MS. To analyze the contribution of type 1 and type 2 cytokine and cytokine receptor genes in the genetic susceptibility to MS, we have examined, in 116 French MS sibpairs, whether there is significant linkage between MS and 15 cytokine or cytokine receptor genes using 31 highly polymorphic genetic markers. The data were analyzed using the maximum likelihood score and the transmission disequilibrium approaches. None of the candidate genes tested was significantly linked to MS on the whole population. However, after stratification of the analysis on the basis of sharing (or not) of the HLA-DRB1*1501 allele, indication of linkage was found for the IL2-RB gene. These findings suggest that the IL2-RB locus contributes to the genetic susceptibility in a subgroup of MS patients. J Neuroimmunol 2000 Jan 3
Source: MS-Highlights
| Home | Doctors | Faqs | Library | Family | Boards | Forums | Webcast | Exchange | Support Group |
|
Your Multiple Sclerosis
Resource
|
International
MS Support Foundation |
|
Bluedomino A company with a heart who didn't think twice about helping with our efforts. Thank you staff for all of your helpful online support. Please show your appreciation by contacting them for your Internet needs. |
Copyright © 1996-2002 International MS Support Foundation |
Sponsored by public
contributions, a grant from Biogen
and long dedicated hours by volunteers with multiple sclerosis.
|
|
Email Jean ©1996-2002 International MS Support Foundation. All rights reserved. Disclaimer: This material is provided as general medical information only and may not include all side effects or details relevant to a particular individual's treatment. Answers are not intended as advice for individual patients; please contact your own physician/neurologist for specific recommendations. |
||